Among them, SETBP1 mutations have been identified in up to 32% of aCML, 24% of JMML, 18% of CMML and 10% of MDS/MPN-U patients. This evidence concerns the gene SETBP1 and atypical chronic myeloid leukemia, BCR-ABL1 negative.